Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Pilot study on the safety of swine immunoglobulin in dogs as a substitute for human intravenous immunoglobulin.
Journal: Journal of veterinary internal medicine
Published: May 16, 2025
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma.
Journal: Cell reports. Medicine
Published: August 23, 2023
Fc multimers effectively treat murine models of multiple sclerosis.
Journal: Frontiers in immunology
Published: April 03, 2023
Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease.
Journal: Frontiers in immunology
Published: December 16, 2019
Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.
Journal: Cells
Published: September 02, 2019
Is routine genetic testing warranted in head and neck paragangliomas?
Journal: The Laryngoscope
Published: October 10, 2018
The evolving role of immuno-oncology for the treatment of head and neck cancer.
Journal: Laryngoscope investigative otolaryngology
Published: July 17, 2018
NK cell expression of Tim-3: First impressions matter.
Journal: Immunobiology
Published: June 26, 2018
Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity.
Journal: Head & neck
Published: June 14, 2018
A recombinant human IgG1 Fc multimer designed to mimic the active fraction of IVIG in autoimmunity.
Journal: JCI insight
Published: May 07, 2018
Recombinant human IgG1 based Fc multimers, with limited FcR binding capacity, can effectively inhibit complement-mediated disease.
Journal: Journal of autoimmunity
Published: May 22, 2017
What additional treatment is indicated for oral cavity cancer with isolated perineural invasion?
Journal: The Laryngoscope
Published: February 16, 2017
Last Updated: 09/26/2026